Wider use of Roche arthritis drug approved
Zurich, August 4, 2011
Roche has won European backing for broader use of its arthritis drug RoActemra to treat children with a rare and severe form of the disease, the Swiss drugmaker said.
The medicine, known as Actemra outside of Europe, is already used to treat adult rheumatoid arthritis in patients who were either intolerant to or failed to respond to other medicines to treat inflammation.
The drug can now also be used in children two years of age and older suffering from active Systemic Juvenile Idiopathic Arthritis (sJIA) who have inadequately responded to previous therapy.
It is already approved in the United States, Mexico, India and Switzerland in this setting, and Vontobel analyst Andrew Weiss said he is carrying a peak sales estimate for the drug of 2 billion Swiss francs ($2.6 billion).
The ailment, which can cause fever, rash and sore joints in children, can also cause enlargement of the liver or spleen and inflammation of the lining of the heart and/or lungs, and has a 2 to 4 percent overall estimated mortality rate.
RoActemra is the first and only biological treatment to demonstrate significant efficacy in this patient population, Roche said in a statement.
Roche is the world's largest maker of cancer drugs and is seeking to bolster its position beyond oncology. -Reuters
More Health & Environment Stories
- CGM acquires 3 European healthcare IT providers
- The age of genomic medicine dawns, finally
- Over 300 exhibitors for Saudi healthcare event
- Mackeen unveils document management solution
- Seha opens new clinics in Abu Dhabi, Al Ain
- SARS virus claims one more victim in Saudi
- New support group comes to overeaters' rescue
- RAK Hospital launches urinary clinic for women
- NBAD backs Emiratis on Antarctica trip
- Cut sugar intake drastically urges WHO
- Al khaliji to fund Qatar recycling plant
- Qatar researcher in 360km breast cancer run
- New facilitator to open in DHCC
- Many countries lack capacity to prevent hearing loss
- QUIT NOW: Passive smoking hurts kids' arteries
- San Francisco to ban plastic water bottles
- GSK wins home toothpaste award for Sensodyne
- E-integration vital to GCC healthcare industry
- Fakih IVF unveils two new genetic tests
- 2 die from H1N1 in Oman
- Al Noor Hospitals targets domestic growth
- Medical panel on the way in Bahrain
- 40pc of UAE adults ‘have hypertension’
- Saudi diabetics urged to stay away from camels
- GCC readies plan to fight heart diseases
- Bahrain opens sickle cell hospital
- Hazardous waste focus for Oman summit
- Infectious viruses to be tracked by satellite in UAE
- Mafraq Hospital names new surgery chief
- Saudi health ministry seals BMJ partnership